A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Clinical trial NCT06419374 · RECRUITING

Trial details

NCT number: NCT06419374
Sponsor: 89bio, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis

Start date: 2024-05-24
Primary completion: 2028-06-01
Enrollment: 762

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.